Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Monograph User Fees Still On The Table, But Not In Legislation

Executive Summary

FDA’s Aug. 23 webinar will update industry stakeholders on progress to modernize its OTC monograph program, but without user fee legislation, new performance goals will not take effect; stakeholders hold out hope a standalone OTC user fee bill could still progress in Congress.

Advertisement

Related Content

Second Wind For OTC Monograph User Fee Legislation In House Hearing
Second Wind For OTC Monograph User Fees Legislation In House Hearing
Waiting For Congress: Reforming, Paying For FDA OTC Monograph Program
Waiting For Congress: Reforming, Paying For FDA OTC Monograph Program
Implementing User Fees Should Be Lighter Lift For FDA This Time Around; Bill Heads To White House
OTC Monograph User Fee Goals Document Beats Authorization To Finish Line
OTC Monograph User Fees Totaling $22m To $34m Floated In Senate Discussion Draft

Topics

Advertisement
UsernamePublicRestriction

Register

PS121313

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel